Mineral disorders in patients with chronic liver disease. Part 2: management

Disorders of mineral metabolism are one of the most significant healthcare challenges in Russia and worldwide. Pathogenetically, they can be caused by various pathologies, including chronic liver diseases (CLD). Mineral metabolism disorders in CLD include hepatic osteodystrophy, osteoporosis, vitamin D deficiency, secondary hyperparathyroidism, hypocalcemia, and others. These disorders are highly prevalent in this patient cohort; however, the lack of unified comprehensive clinical guidelines hinders the timely detection of these complications of CLD. In the first part of the review, we examined the epidemiology and pathophysiology of mineral metabolism disorders in CLD, while the second part focuses on their diagnosis. 

1. Handzlik-Orlik G, Holecki M, Wilczyński K, Duława J. Osteoporosis in liver disease: pathogenesis and management. Ther Adv Endocrinol Metab. 2016;7(3):128-135. doi: https://doi.org/10.1177/2042018816641351

2. López-Larramona G. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol. 2011;3(12):300. doi: https://doi.org/10.4254/wjh.v3.i12.300

3. Guañabens N, Parés A. Osteoporosis in chronic liver disease. Liver International. 2018;38(5):776-785. doi: https://doi.org/10.1111/liv.13730

4. Gorbacheva AM, Bibik EE, Lavreniuk AA, Eremkina AK, Tikhonov IN, Mokrysheva NG. Mineral disorders in patients with chronic liver disease. Part 1: epidemiology and pathophysiology. Obe Metab. 2024;21(4):373-381. doi: https://doi.org/10.14341/omet13124

5. Merli M, Berzigotti A, Zelber-Sagi S, et al. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172-193. doi: https://doi.org/10.1016/j.jhep.2018.06.024

6. Nompleggi DJ, Bonkovsky HL. Nutritional supplementation in chronic liver disease: An analytical review. Hepatology. 1994;19(2):518-533. doi: https://doi.org/10.1002/hep.1840190234

7. Thuluvath P, Triger D. Evaluation of nutritional status by using anthropometry in adults with alcoholic and nonalcoholic liver disease. Am J Clin Nutr. 1994;60(2):269-273. doi: https://doi.org/10.1093/ajcn/60.2.269

8. Matos C, Porayko MK, Francisco-Ziller N, DiCecco S. Nutrition and Chronic Liver Disease. J Clin Gastroenterol. 2002;35(5):391-397. doi: https://doi.org/10.1097/00004836-200211000-00007

9. Shams-White MM, Chung M, Du M, et al. Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation. Am J Clin Nutr. 2017;105(6):1528-1543. doi: https://doi.org/10.3945/ajcn.116.145110

10. Holick MF. Vitamin D Deficiency. New England Journal of Medicine. 2007;357(3):266-281. doi: https://doi.org/10.1056/NEJMra070553

11. Lips P. Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications. Endocr Rev. 2001;22(4):477-501. doi: https://doi.org/10.1210/edrv.22.4.0437

12. Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: Clinical nutrition in liver disease. Clinical Nutrition. 2020;39(12):3533-3562. doi: https://doi.org/10.1016/j.clnu.2020.09.001

13. Baker JP, Detsky AS, Wesson DE, et al. Nutritional Assessment. New England Journal of Medicine. 1982;306(16):969-972. doi: https://doi.org/10.1056/NEJM198204223061606

14. Álvares-da-Silva M ário R, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21(2):113-117. doi: https://doi.org/10.1016/j.nut.2004.02.002

15. Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver International. 2013;33(3):338-352. doi: https://doi.org/10.1111/liv.12106

16. Rech MA, Von Roenn N, Durazo-Arvizu R, Cotler SJ, Kramer H. Vitamin D Levels are Associated with Liver Disease Severity in Patients with Cirrhosis. Journal of Renal and Hepatic Disorders. 2017;1(2):1-9. doi: https://doi.org/10.15586/jrenhep.2017.15

17. Collier J. Bone disorders in chronic liver disease. Hepatology. 2007;46(4):1271-1278. doi: https://doi.org/10.1002/hep.21852

18. Barchetta I, Angelico F, Ben M Del, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9(1):85. doi: https://doi.org/10.1186/1741-7015-9-85

19. Nimer A. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol. 2012;18(8):800. doi: https://doi.org/10.3748/wjg.v18.i8.800

20. Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671-722. doi: https://doi.org/10.1002/hep.31065

21. You H, Ma X, Efe C, et al. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int. 2022;16(1):1-23. doi: https://doi.org/10.1007/s12072-021-10276-6

22. Kim DS, Yoon YI, Kim BK, et al. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatol Int. 2024;18(2):299-383. doi: https://doi.org/10.1007/s12072-023-10629-3

23. Yousif MM, Sadek AMEM, Farrag HA, Selim FO, Hamed EF, Salama RI. Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis. Intern Emerg Med. 2019;14(5):753-761. doi: https://doi.org/10.1007/s11739-019-02042-2

24. Danish MR, Sarker SS, Rahman MdA, et al. Association of Serum Vitamin D and Calcium with Different Stages of Chronic Liver Diseases. Scholars Journal of Applied Medical Sciences. 2023;11(08):1469-1473. doi: https://doi.org/10.36347/sjams.2023.v11i08.015

25. Locquet M, Beaudart C, Bruyère O, Kanis JA, Delandsheere L, Reginster JY. Bone health assessment in older people with or without muscle health impairment. Osteoporosis International. 2018;29(5):1057-1067. doi: https://doi.org/10.1007/s00198-018-4384-1

26. Lai JC, Tandon P, Bernal W, et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(3):1611-1644. doi: https://doi.org/10.1002/hep.32049

27. Marasco G, Sadalla S, Vara G, et al. Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning. Can J Gastroenterol Hepatol. 2021;2021:1-7. doi: https://doi.org/10.1155/2021/6669480

28. Han JW, Kim DI, Nam HC, Chang UI, Yang JM, Song DS. Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis. Clin Mol Hepatol. 2022;28(2):219-231. doi: https://doi.org/10.3350/cmh.2021.0082

29. Zeng X, Shi Z, Yu J, et al. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle. 2021;12(6):1948-1958. doi: https://doi.org/10.1002/jcsm.12797

30. Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatology Research. 2016;46(10):951-963. doi: https://doi.org/10.1111/hepr.12774

31. Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end‐stage liver disease. Liver Transplantation. 2017;23(5):625-633. doi: https://doi.org/10.1002/lt.24750

32. Marcus RL, Addison O, Kidde JP, Dibble LE, Lastayo PC. Skeletal muscle fat infiltration: Impact of age, inactivity, and exercise. J Nutr Health Aging. 2010;14(5):362-366. doi: https://doi.org/10.1007/s12603-010-0081-2

33. Becchetti C, Berzigotti A. Ultrasonography as a diagnostic tool for sarcopenia in patients with cirrhosis: Examining the pros and cons. Eur J Intern Med. 2023;116:27-33. doi: https://doi.org/10.1016/j.ejim.2023.06.019

34. Nicoll R, Black A, Bailey L, et al. PWE-140 Fracture risk tool reduces need for dexa scanning in cirrhosis patients. Gut. 2015;64(Suppl 1):A274.1-A274. doi: https://doi.org/10.1136/gutjnl-2015-309861.588

35. Sánchez-Delgado J, Profitós J, Arévalo M, et al. Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX® as a Screening Tool. J Clin Med. 2023;13(1):188. doi: https://doi.org/10.3390/jcm13010188

36. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129

37. Labio ED, Del Rosario DB, Strasser SI, McCaughan GW, Crawford BA. Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry. 2007;10(4):391-394. doi: https://doi.org/10.1016/j.jocd.2007.07.001

38. Yu EW, Thomas BJ, Brown JK, Finkelstein JS. Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. Journal of Bone and Mineral Research. 2012;27(1):119-124. doi: https://doi.org/10.1002/jbmr.506

39. Shuhart CR, Yeap SS, Anderson PA, et al. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. Journal of Clinical Densitometry. 2019;22(4):453-471. doi: https://doi.org/10.1016/j.jocd.2019.07.001

40. Kalender WA, Deak P, Kellermeier M, van Straten M, Vollmar S V. Application‐ and patient size‐dependent optimization of x‐ray spectra for CT. Med Phys. 2009;36(3):993-1007. doi: https://doi.org/10.1118/1.3075901

41. Khoroushi F, Keykhosravi E, Shakeri MT, et al. Opportunistic screening for osteoporosis using computed tomography scans and its comparison with DXA findings: a two-center cross-sectional study. Egyptian Rheumatology and Rehabilitation. 2024;51(1):20. doi: https://doi.org/10.1186/s43166-024-00253-w

42. Kazawa N. T2WI MRI and MRI-MDCT correlations of the osteoporotic vertebral compressive fractures. Eur J Radiol. 2012;81(7):1630-1636. doi: https://doi.org/10.1016/j.ejrad.2011.04.052

43. Raszeja-Wyszomirska J, Miazgowski T. Osteoporosis in primary biliary cirrhosis of the liver. Gastroenterology Review. 2014;2:82-87. doi: https://doi.org/10.5114/pg.2014.42502

44. Schönau J, Wester A, Schattenberg JM, Hagström H. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study. J Intern Med. 2023;294(2):164-177. doi: https://doi.org/10.1111/joim.13624

45. Schönau J, Wester A, Schattenberg JM, Hagström H. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study. J Intern Med. 2023;294(2):164-177. doi: https://doi.org/10.1111/joim.13624

46. Menon KVN, Angulo P, Weston S, Dickson ER, Lindor KD. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol. 2001;35(3):316-323. doi: https://doi.org/10.1016/S0168-8278(01)00144-1

47. Chazouilleres O, Beuers U, Bergquist A, et al. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022;77(3):761-806. doi: https://doi.org/10.1016/j.jhep.2022.05.011

48. Bowlus CL, Arrivé L, Bergquist A, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023;77(2):659-702. doi: https://doi.org/10.1002/hep.32771

49. Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69(1):394-419. doi: https://doi.org/10.1002/hep.30145

50. Nuti R, Brandi ML, Checchia G, et al. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med. 2019;14(1):85-102. doi: https://doi.org/10.1007/s11739-018-1874-2

51. American gastroenterological association medical position statement: osteoporosis in hepatic disorders. Gastroenterology. 2003;125(3):937-940. doi: https://doi.org/10.1016/S0016-5085(03)01060-6

52. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64(2):433-485. doi: https://doi.org/10.1016/j.jhep.2015.10.006

53. Hirschfield GM, Beuers U, Corpechot C, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145-172. doi: https://doi.org/10.1016/j.jhep.2017.03.022

54. Zoller H, Schaefer B, Vanclooster A, et al. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022;77(2):479-502. doi: https://doi.org/10.1016/j.jhep.2022.03.033 55. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015;63(4):971-1004. doi: https://doi.org/10.1016/j.jhep.2015.06.030

55. Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144-1165. doi: https://doi.org/10.1002/hep.26972

56. American Gastroenterological Association. American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology. 2003;125(3):937-940. doi: https://doi.org/10.1016/s0016-5085(03)01060-6

57. Xu XY, Ding HG, Li WG, et al. Chinese guidelines on the management of liver cirrhosis (abbreviated version). World J Gastroenterol. 2020;26(45):7088-7103. doi: https://doi.org/10.3748/wjg.v26.i45.7088

58. Collier JD. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut. 2002;50(90001):1i-19. doi: https://doi.org/10.1136/gut.50.suppl_1.i1

59. Puri P, Dhiman RK, Taneja S, et al. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol. 2021;11(1):97-143. doi: https://doi.org/10.1016/j.jceh.2020.09.003

60. Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus. Hepatology. 2013;58(1):325-336. doi: https://doi.org/10.1002/hep.26370